Acurx Pharmaceuticals

ACXPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.561 M

$1.36 +2.26%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$7.97M

Loss-making

Shares outstanding

5,269,921

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#448InMed PharmaceuticalsINM$7.64M
#449Skye BioscienceSKYE$7.57M
#450Acurx PharmaceuticalsACXP$7.56M
#451Curanex PharmaceuticalsCURX$7.18M
#452Bolt BiotherapeuticsBOLT$7.15M

What if Acurx Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$5,438,346

Per share 3,998,784× higher

Bitcoin $1.74T

$313,280.83

Per share 230,354× higher

Nvidia $5.52T

$992,150.57

Per share 729,522× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Acurx Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.